We studied the effect of peritoneal dialysis solution (PDS) on the antibacterial activity of seven cephalosporins, gentamicin, tobramycin and amikacin. The six bacterial species employed in the study survived in a wide range of concentrations of PDS, however, Staphylococcus aureus did not survive beyond 24 h in PDS. There were no physical incompatibilities between any of the antibiotics and PDS. None of the cephalosporins was bactericidal in PDS, whereas, the bactericidal concentrations of the aminoglycosides in PDS approximated those of aminoglycosides in broth. We conclude from these in vitro data that cephalosporins may not be ideal agents for intraperitoneal therapy when they are administered in PDS.
16. BACHMANN W. HASCHE H. MEHNERT H. Intradermal desensitization with human insulin (recombinant DNA) in a patient with severe allergic skin reaction to insulin. Diabetes Care 1982; 5:165-7. EXTRACTO Los autores reportan un procedimiento de desensitizaci6n utilizando insulina de origen humano (DNA recombinante) en una paciente alergica a insulina. Una paciente de 34 afios de edad desarro1l6 diabetes gestacional y fue tratada durante diferentes periodos con insulina de diverso origen y terapia oral. La paciente desarro1l6 una alergia a insulina, sin embargo, intentos de desensitizaci6n utilizando el material comercial disponible que contiene insulina porcina purificada no fueron exitosos. Se demostr6 reactividad a la insulina humana (DNA recombinante) como tam bien niveles de IgE elevados y eosinofilia. Un segundo intento de desensitizaci6n utilizando insulina de origen humano (DNA recombinante) usando un protocolo desarrollado por los autores fue exitoso. Los autores concluyen que existe la posibilidad de que esta nueva tecnica pudiera ser beneficiosa en el 10 por ciento CASE REPORTS de los pacientes que no pueden ser desensitizados con otros productos. Sin embargo, estudios adicionales son necesarios para confirmar cualquier superioridad de otros rnetodos sobre el protocolo que utiliza insulina porcina purificada en la desensitizaci6n de estos pacientes.BRENDA R. MORAND RESUME L'allergie locale ou meme generalisee est une complication peu frequente de l'insulinotherapie. L'usage d'insulines animales purifiees permet habituellement de traiter cette complication. L'insuline humaine, quant it elle, semble encore moins allergene que les insulines animales les plus purifiees, De rares cas d'allergie ont neanmoins ete rapportes.Les auteurs decrivent un tel cas d'allergie it l'insuline humaine biosynthetique (produite par recombinaison de I'ADN), ainsi qu'une desensibilisation reussie selon un protocole entierernent nouveau. Celui-ci est decrit de facon detaillee. D'ici it l'avenement prochain d'une trousse de desensibilisation it l'insuline Humulin, d'EIi Lilly et Compagnie, ce protocole peut s'averer utile au traitement des diabetiques hypersensibles it I'insuline humaine biosynthetique.ALAIN BOISVERT ABSTRACT: Quinidine pharmacokinetics are known to be altered by a number of drugs. We present a case where dose-related increases in quinidine serum concentrations were significantly suppressed by concurrent nifedipine therapy. Clinicians should be alert to the possibility of an alteration in quinidine serum concentrations when instituting or discontinuing nifedipine in patients receiving quinidine.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.